Pages

Monday, October 1, 2018

FDA Approves New Treatment for Squamous Cell Carcinoma

... Breakthrough Therapy and Priority Review designations. Libtayo is produced by Regeneron Pharmaceuticals, based in Tarrytown, N.Y.
https://www.drugs.com/news/fda-approves-new-squamous-cell-carcinoma-77461.html?

No comments:

Post a Comment